Eli Lilly Says Canada Skewing Facts In $354M IP Arbitration
Eli Lilly has blasted the Canadian government's argument that a purported shift in the focus of its CA$500 million ($354 million) dispute over the country's cancellation of its patents for Strattera...To view the full article, register now.
Already a subscriber? Click here to view full article